Low but substantial frequencies of specific CD4+ and CD8+ T cells were detected in the blood of COVID-19 patients compared to healthy donors, both at baseline and on day 7, thus highlighting the onset of an anti-viral response in COVID-19 patients (Figures 8A–D). This evidence concerns the gene CD8A and COVID-19.